Boron-containing compositions and methods therefor
AssigneeVDF Futureceuticals, Inc.
InventorZbigniew Pietrzkowski
Life of this patent
Estimating the term…
Abstract
Contemplated boro-carbohydrate compounds are demonstrated to modulate the blood concentrations of various polypeptides associated with metabolic syndrome by administration of a tetrahedral, and under-carboxylated osteocalcin, adiponectin, and YKL-40. Use of such compounds in oral administration is especially preferred and may be effective to address one or more components of metabolic syndrome.
Claims20
A method of reducing the concentration of under-carboxylated osteocalcin in the blood of a mammal, comprising administering a boro-carbohydrate complex at a dosage and schedule effective to reduce the concentration of under-carboxylated osteocalcin in blood.
A method of increasing the concentration of adiponectin in the blood of a mammal, comprising administering a boron-carbohydrate complex at a dosage and schedule effective to increase the concentration of adiponectin in blood.
A method of reducing the concentration of YKL-40 in the blood of a mammal, comprising administering a boro-carbohydrate complex at a dosage and schedule effective to reduce the concentration of YKL-40 in blood.
Dependencies are inferred from the claim text.